DprE1-IN-1

• CAT Number: I001841
• CAS Number: 1494675-86-3
• Molecular Formula: C18H21N5O3
• Molecular Weight: 355.4
• Purity: ≥95%
• Synonyms: N-(2-hydroxyethyl)-1-[(6-methoxy-5-methyl-4-pyrimidinyl)methyl]-6-methyl-1H-pyrrolo[3,2-b]pyridine-3-carboxamide
• Target: DprE1
• Solubility: DMSO: ≤ 11 mg/mL
• Storage: Store at -20°C
• IC50: 10 nM [1]
• IUPAC Name: N-(2-hydroxyethyl)-1-[(6-methoxy-5-methylpyrimidin-4-yl)methyl]-6-methylpyrrolo[3,2-b]pyridine-3-carboxamide
• InChI: InChI=1S/C18H21N5O3/c1-11-6-15-16(20-7-11)13(17(25)19-4-5-24)8-23(15)9-14-12(2)18(26-3)22-10-21-14/h6-8,10,24H,4-5,9H2,1-3H3,(H,19,25)
• InChIKey: VDRYGTNDKXIPSK-UHFFFAOYSA-N
• SMILES: COC1=C(C)C(CN2C=C(C(NCCO)=O)C3=C2C=C(C)C=N3)=NC=N1

DprE1-IN-1 (Cat.No:I001841) is a chemical compound with potential antimycobacterial activity. It targets the enzyme decaprenylphosphoryl-β-D-ribose 2′-epimerase (DprE1), involved in the biosynthesis of cell wall components in Mycobacterium tuberculosis. By inhibiting DprE1, DprE1-IN-1 shows promise in the development of new treatments for tuberculosis. 

Reference

[1]. Shirude PS, et al. Lead optimization of 1,4-azaindoles as antimycobacterial agents. J Med Chem. 2014 Jul 10;57(13):5728-37.
[2]. Chatterji M, et al. 1,4-azaindole, a potential drug candidate for treatment of tuberculosis. Antimicrob Agents Chemother. 2014 Sep;58(9):5325-31.